Blog

Why PCOS is Being Renamed PMOS: Everything You Need to Know

PCOS has been renamed as PMOS. On 12 May 2026, The Lancet announced that Polycystic Ovary Syndrome would now be called Polyendocrine Metabolic Ovarian Syndrome, or PMOS for short. Even though only one letter has changed, this carries a lot of weight. If you have been searching for what is PMOS, the short answer is this: it is the updated, more accurate name for the condition millions of women have lived with for decades, and it reflects how one should understand the disorder as something that goes well beyond the ovaries.

A Look Back: Where Did the Name "PCOS" Come From?

The story starts in 1935, when two doctors named Irving Stein and Michael Leventhal were examining women with irregular periods and unexplained hormonal symptoms. During surgery, they spotted small, fluid filled sacs on the ovaries and assumed these were cysts, and that's how it was named "polycystic ovarian syndrome".

Those little sacs were never actually cysts, they are follicles, tiny structures that hold eggs and are trying, often unsuccessfully, to mature and release one each month. Research has since shown that women with this condition are not at any higher risk of developing true ovarian cysts than anyone else. So for close to around 90 years, the name we have all used has not quite matched the biology.

So why bother changing it now?

This is where what is PMOS starts to make more sense as a question worth asking. The old name put almost all the attention on the ovaries and on fertility. Plenty of women assumed they had ovarian cysts when they didn't. Others believed the condition only mattered if they were trying to conceive, and many healthcare professionals, working from the name alone, focused their conversations narrowly on periods and pregnancy.

But this hormonal and metabolic disorder touches far more of the body than that. It can influence:

  • Insulin resistance and blood sugar regulation
  • Weight and how the body stores fat
  • Acne
  • Excess hair growth on the body or face
  • Thinning hair on the scalp
  • Mood, including higher rates of anxiety and low mood
  • Long term risk of type 2 diabetes
  • Long-term morbidity like heart health

Naming only the ovaries left all of this in the shadows. That is the gap the new name is trying to close.

How the Renaming Actually Happened

It is important to understand that this decision to rename wasn't decided overnight by a handful of committee members. The process began nearly fourteen years ago, led by Professor Helena Teede at Monash University in Australia. Over time, she brought together an international group involving 56 clinical, academic, and patient organisations spanning six continents.

More than 14,000 patients and healthcare professionals took part in surveys and discussions before anything related to this was finalised. Around 86% of patients and 71% of clinicians who responded were in favour of a new name. That is not a small consensus, and it shows how many people felt the old term was falling short.

The group agreed the replacement name needed to do a few things: reflect current medical understanding, make sense to patients without confusion, reduce the stigma some women feel around the diagnosis. After years of back and forth, Polyendocrine Metabolic Ovarian Syndrome was the name that met all those marks. 

Breaking Down the New Name

PCOS to PMOS is really about adding precision where it was missing before.


P for Polyendocrine. "Poly" means many. "Endocrine" refers to hormones. This condition doesn't involve just one hormone acting up. Androgens, insulin, and anti-Müllerian hormone (AMH) all interact with each other in ways that are still being studied.

M for Metabolic. This is the biggest addition, and arguably the most important. A large share of women with the condition, somewhere around 85%, deal with some degree of insulin resistance. That figure includes roughly 75% of women who are not overweight, which surprises a lot of people. Adding "metabolic" makes the whole-body nature of the condition impossible to ignore.

O for Ovarian. The ovaries are still a part, and keeping this word “ovary” means the transition from the old name to the new one doesn't feel jarring or unfamiliar.

S for Syndrome. This simply means it is a cluster of signs and symptoms that, together, point to a diagnosis rather than a single, isolated problem.

Does the Diagnosis Itself Change?

No. This is one of the more reassuring parts of the update, and the diagnostic criteria also remain exactly the same. For diagnosis, doctors still look for two out of three of the following:

  • Irregular or unpredictable periods caused by irregular ovulation
  • Signs of raised androgens
  • A polycystic appearance on ultrasound


What has shifted is the framing. You no longer need a "polycystic" ovarian appearance to receive a diagnosis, and the conversation with your doctor is no longer expected to centre only on your fertility.

Questions Worth Asking Your Doctor

If you have been told you have PCOS, now PMOS, here are three things worth raising at your next appointment:

  1. Beyond periods and fertility, what should I be keeping an eye on for my long term health?
  2. Should I be screened for insulin resistance, cholesterol, or cardiovascular risk?
  3. Based on my specific symptoms, are there other hormone or metabolic tests that might help guide my care?


These questions push the conversation towards the fuller picture that the name change was meant to bring into focus.

PMOS Management

This isn't a cosmetic rebrand. It's a shift in how the medical community understands and treats a condition that affects roughly one in eight women worldwide, over 170 million people. If you have been diagnosed with PCOS, or you suspect you might have symptoms that fit, our gynaecology team at EMC Hospital can help you look at the full picture: your hormones, your metabolism, and your long term wellbeing, not just one part of it.

If you would like to speak with one of our specialists or book a consultation, get in touch with us at EMC Hospital. 

Frequently Asked Questions (FAQs)

Q1: What is PMOS? 
A1: PMOS stands for Polyendocrine Metabolic Ovarian Syndrome, the new name for what was previously called PCOS. It was adopted in May 2026 to better reflect how the condition affects hormones and metabolism, not just the ovaries.

Q2: Do I need a new diagnosis if I already have PCOS? 
A2: No, you don't need a fresh diagnosis. The diagnostic criteria haven't changed, so if you were diagnosed with PCOS, you now simply fall under the updated name, PMOS, and your existing treatment plan still applies unless your doctor suggests otherwise based on a routine review.

Q3: Why does the name change matter if the symptoms are the same? 
A3: Because names shape how a condition is understood and treated. The old name led many people, including some clinicians, to focus almost entirely on the ovaries and fertility. The new name makes the hormonal and metabolic aspects impossible to overlook, which can lead to earlier screening for things like insulin resistance and heart health.

2026-07-27
PCOS is Being Renamed PMOS:

More Blogs

For Appointments and General Enquiry

0484 2907000 , 0484 4507000

24X7 Emergency

0484 2807266

emc